Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The C1 complex is the first component of the classical complement pathway, composed of C1q, C1r, and C1s subunits. It initiates the pathway upon binding to antibody-antigen complexes, leading to activation of C1r and C1s serine proteases, which cleave downstream complement components and propagate the complement cascade. Dysregulation can lead to autoimmune and inflammatory diseases.
Inhibition of C1r and C1s serine protease activity; preventing cleavage of downstream complement components C4 and C2
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Complement C1 complex (C1).